Anzeige
Mehr »
Login
Mittwoch, 25.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Diese Firma hat die Grundlagen, um zu einem Goldkraftwerk zu werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6WD | ISIN: GB00BG0TPX62 | Ticker-Symbol: FCA
Frankfurt
25.09.24
09:59 Uhr
1,470 Euro
-0,060
-3,92 %
1-Jahres-Chart
FUNDING CIRCLE HOLDINGS PLC Chart 1 Jahr
5-Tage-Chart
FUNDING CIRCLE HOLDINGS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4701,61012:25
Dow Jones News
131 Leser
Artikel bewerten:
(0)

Funding Circle Plc: HOL-Holding(s) in Company

DJ Funding Circle Plc: HOL-Holding(s) in Company*

Funding Circle Plc (FCH) 
Funding Circle Plc: HOL-Holding(s) in Company* 
23-Sep-2024 / 08:03 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
 
TR-1: Standard form for notification of major holdings 
 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 
i 
 
1a. Identity of the issuer or the underlying issuer of existing   FUNDING CIRCLE HOLDINGS PLC 
shares to which voting rights are attached ii: 
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) 
Non-UK issuer 
2. Reason for the notification (please mark the appropriate box or boxes with an "X") 
An acquisition or disposal of voting rights                         X 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights 
Other (please specify) iii: 
3. Details of person subject to the notification obligation iv 
Name                                Zedra Trust Company (Guernsey) 
City and country of registered office (if applicable)        St Peter Port, Guernsey 
4. Full name of shareholder(s) (if different from 3.) v 
Name 
City and country of registered office (if applicable) 
5. Date on which the threshold was crossed or reached vi:      17/9/2024 
6. Date on which issuer notified (DD/MM/YYYY):           19/9/2024 
7. Total positions of person(s) subject to the notification obligation 
                             % of voting rights 
                 % of voting rights   through financial   Total of both Total number of voting 
                 attached to shares   instruments      in % (8.A +  rights held in issuer (8.A 
                 (total of 8. A)     (total of 8.B 1 + 8.B 8.B)     + 8.B) vii 
                             2) 
Resulting situation on the date 
on which threshold was crossed  2.90          0           2.90      9,790,389 
or reached 
Position of previous 
notification (if         3.90          0           3.90     13,941,138 
applicable) 
 
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii 
A: Voting rights attached to shares 
Class/type of    Number of voting rights ix       % of voting rights 
shares 
           Direct   Indirect           Direct                    Indirect 
ISIN code (if 
possible)      (DTR5.1)  (DTR5.2.1)         (DTR5.1)                   (DTR5.2.1) 
GB00BG0TPX62     9,790,389               2.90 
 
 
SUBTOTAL 8. A    9,790,389                2.90 
 
B 1: Financial Instruments according to DTR5.3.1R (1) (a) 
                           Number of voting rights that may be acquired if the 
Type of financial  Expiration Exercise/       instrument is                    % of voting 
instrument      date x   Conversion Period xi                            rights 
                           exercised/converted. 
 
 
 
                SUBTOTAL 8. B 1 
 
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) 
                        Physical or 
Type of financial  Expiration Exercise/   cash                            % of voting 
instrument      date x   Conversion          Number of voting rights            rights 
                Period xi   Settlement 
                        xii 
 
 
 
                        SUBTOTAL 
                        8.B.2 
 
 
9. Information in relation to the person subject to the notification obligation (please mark the 
applicable box with an "X") 
Person subject to the notification obligation is not controlled by any natural person or 
legal entity and does not control any other undertaking(s) holding directly or      X 
indirectly an interest in the (underlying) issuer xiii 
Full chain of controlled undertakings through which the voting rights and/or the 
financial instruments are effectively held starting with the ultimate controlling 
natural person or legal entity (please add additional rows as necessary) xiv 
       % of voting rights if it    % of voting rights through financial    Total of both if it equals or 
Name xv    equals or is higher than the  instruments if it equals or is higher than is higher than the notifiable 
       notifiable threshold      the notifiable threshold          threshold 
 
 
 
 
 
 
10. In case of proxy voting, please identify: 
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will 
be held 
 
11. Additional information xvi 
 
Place of completion London, UK 
Date of completion  19 September 2024 

Notes

i Please note this form should be read jointly with the applicable Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the following link: https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the agreement referred to in DTR5.2.1 (a) or (d) the holder of financial instruments referred to in DTR5.3.1.

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

In relation to the transactions referred to in DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal entity that controls the voting rights;

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

v Applicable in the cases provided for in DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to DTR5.2 unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

vii The total number of voting rights held in the issuer shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

viii If the holding has fallen below the lowest applicable threshold, please note that it might not be necessary to disclose the extent of the holding, only that the new holding is below that threshold.

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only in this way will the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain by numbering each chain accordingly. Please see the below example:

Name of ultimate controlling person A (chain 1)

Name of controlled undertaking B

Name of controlled undertaking C

Name of ultimate controlling person A (chain 2)

Name of controlled undertaking B

Name of controlled undertaking D

Name of ultimate controlling person A (chain3)

Name of controlled undertaking E

Name of controlled undertaking F

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

xvi Example: Correction of a previous notification.

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BG0TPX62 
Category Code: HOL 
TIDM:      FCH 
LEI Code:    2138003EK6UAINBBUS19 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:  348267 
EQS News ID:  1992887 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1992887&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

September 23, 2024 03:03 ET (07:03 GMT)

© 2024 Dow Jones News
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.